6446 藥華藥歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 87.50% | 30.41% | 2.66% | 23.10% |
| 2025Q1 | 88.87% | 33.93% | 44.84% | 38.79% |
| 2024Q4 | 88.38% | 17.68% | 27.83% | 40.36% |
| 2024Q3 | 87.92% | 27.07% | 32.49% | 26.52% |
| 2024Q2 | 86.98% | 19.19% | 40.17% | 29.47% |
| 2024Q1 | 88.31% | 1.06% | 20.24% | 19.98% |
| 2023Q4 | 84.73% | -8.02% | -13.04% | 7.04% |
| 2023Q3 | 90.68% | -49.84% | 14.61% | 15.20% |
| 2023Q2 | 91.77% | -32.01% | -16.05% | -16.03% |
| 2023Q1 | 85.00% | -81.73% | -85.62% | -82.86% |
| 2022Q4 | 88.18% | -68.88% | -73.36% | -17.87% |
| 2022Q3 | 75.92% | -69.67% | -50.42% | -50.42% |
| 2022Q2 | 59.42% | -33.40% | -28.10% | -28.10% |
| 2022Q1 | 52.04% | -221.24% | -214.84% | -214.84% |
| 2021Q4 | 56.50% | -250.50% | -233.37% | -233.37% |
| 2021Q3 | 25.86% | -763.89% | -760.72% | -760.72% |
| 2021Q2 | 19.65% | -626.44% | -623.17% | -623.17% |
| 2021Q1 | 22.59% | -638.55% | -699.42% | -699.42% |
| 2020Q4 | 48.50% | -227.14% | -285.13% | -284.60% |
| 2020Q3 | -10.07% | -404.89% | -460.75% | -461.69% |
| 2020Q2 | 42.89% | -169.04% | -158.69% | -159.01% |